毒性甲状腺肿

利用放射性核素131I治疗弥漫性毒性甲状腺肿已经成为临床的主要方法之一。

The use of radionuclide131I in treatment of diffuse toxic goiter has become one of the main clinical methods .

方法分析16例毒性甲状腺肿合并甲状腺隐性癌病例的临床及病理资料。

Methods 16 cases of toxic goiter complicated by occult carcinoma were analysed .

目的对131I治疗非毒性甲状腺肿（NTG）进行临床评价。

Objective To evaluate the therapy of nontoxic goiter with 131 I.

目的：探讨弥漫性毒性甲状腺肿（Gravesdisease，GD）对人体血清白细胞介素-2（IL-2）、白细胞介素-8（IL-8）、肿瘤坏死因子（TNF）水平的影响。

Objective : To evaluate the influence of Graves disease on the serum levels of interleukin-2 ( IL-2 ), interleukin-8 ( IL-8 ) and TNF .

目的探讨非毒性甲状腺肿人群血清甲状腺球蛋白（Tg）和促甲状腺素（TSH）的相关性。

Objective To investigate the correlation between serum thyroglobulin ( Tg ) and thyroid stimulating hormone ( TSH ) in populations with non toxic goiter .

目的观察弥散性毒性甲状腺肿（GD）儿童在疾病不同阶段血清IL-10、12水平变化的临床意义。

Objective To study the levels of interleukin-10 ( IL-10 ) and IL-12 in serum of patients with Graves disease ( GD ) in different stage of disease and its clinical significance .

非毒性甲状腺肿、特别是高碘甲状腺肿存在自身免疫异常。

Nontoxic goiters especially iodine excessive-goiter presented abnormally on the autoimmune analysis .

非毒性甲状腺肿人群血清甲状腺球蛋白和促甲状腺素水平相关性研究

Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter

~（131）I治疗非毒性甲状腺肿临床分析

Clinical analysis on treatment of nontoxic goiter with ~ ( 131 ) I nuclide

弥漫性毒性甲状腺肿的二维及彩色多普勒超声特征

The Characteristics of Two - dimensional and Color Doppler Ultrasonography in Graves ' Disease

~（131）Ⅰ治疗非毒性甲状腺肿的疗效观察

The therapeutic effect of ~ ( 131 )ⅰ for the treatment of nontoxic goiter

~（131）I治疗毒性甲状腺肿合并肝损害27例临床观察

27 clinical survey of ~ ( 131 ) I cure Graves disease combined with liver damage

结论131Ⅰ治疗非毒性甲状腺肿安全、简便、有效。

Conclusion 131 ⅰ is an effective , simple and safe method for the treatment of nontoxic goiter .

结论毒性甲状腺肿对隐性癌有阻抑作用，可作为良性病变处理。

Conclusions The toxic goiter restrains the development of occult cancer lesions , which could be considered and managed as benign lesions .

本课题研究的非毒性甲状腺肿指单纯性甲状腺肿和甲状腺腺瘤，是临床常见的内分泌系统疾病，由精神、环境、遗传等因素引起，以甲状腺弥漫性或结节性肿大而不伴有甲亢为特征。

Non-toxic goiter , such as single goiter and thyroid adenoma , not complicated with hyperthyroidism , is a common disease of endocrine system and often caused by psychic , environmental or genetic factors .

毒性弥漫性甲状腺肿患者血清IL-1、IL-2、IL-6水平变化的分析

The Changes of Serum IL-1 、 IL-2 and IL-6 Levels in Graves Disease Patients

Graves病、继发性甲减、Graves眼病和部分非毒性结节性甲状腺肿患者TSH昼夜节律消失。

It disappears in patiens with Graves disease , secondary hypothyroidism , Graves ophthalmopathy and a part of nontoxic nodular goitre .

本文报道一例毒性弥漫性甲状腺肿患者合并有胰岛素自身免疫综合症（IAS）。

A case of insulin autoimmune syndrome ( IAS ) is reported and the related literature reviewed .

目的：探讨抗甲状腺药物（ATD）对毒性弥漫性甲状腺肿即Graves病（GD）患者治疗前后心率变异性（HRV）的影响。

To study the effect of anti-thyroid drug ( ATD ) on heart rate variation ( HRV ) in patients with Graves disease ( GD ) .

方法选取21例Graves病（GD）患者、18例桥本甲状腺炎（HT）患者，17例非毒性结节性甲状腺肿（NTNG）患者，20例正常人作为对照进行研究。

Methods 21 patients with Graves'desease ( GD ), 18 cases with Hashimoto 's thyroiditis ( HT ), 17 cases with non-toxic nodular goiter ( NTNG ) and 20 healthy subjects were enrolled in this study .

毒性弥漫性甲状腺肿合并周期性麻痹临床分析

Clinical analysis of graves ' disease accompanied with periodic paralysis

毒性弥漫性甲状腺肿1例（1.3%）。

Diffuse toxic goiter 1 case ( 1.3 % ) .

毒性弥漫性甲状腺肿病人的健康教育

Health education of patients with Graves disease

毒性弥漫性甲状腺肿~（131）I治疗病人的护理

Nursing care of patients with Graves disease underwent Iodine ( ~ ( 131 ) I ) therapy

目的：观察中药泻火养阴散治疗初发毒性弥漫性甲状腺肿（格雷夫斯病）的治疗效果。

Objective : To observe the therapeutic effect of Xiehuo Yangyin powder ( XHYY ) in treating the initial stage of toxic and diffuse goiter ( Graves disease ) .

本文对单纯性甲状腺肿、毒性弥漫性甲状腺肿、亚急性甲状腺炎和桥本甲状腺炎引起的112例弥漫性甲状腺肿的B超显像、临床表现和实验室检查结果进行了综合分析。

112 cases with diffuse thyromegaly resulted from simple goiter , subacute thyroiditis . hashimoto thyroiditis and toxic diffuse goiter were examined with B-mode ultrasonography , The results were compared with clinical presentation and laboratory investigation .